SEC Company Response from Zhong Yuan Bio-Technology Holdings Ltd (ZHYBF) (CIK 0001672886) — Jul 18, 2022
Zhong Yuan Bio-Technology Holdings Ltd (ZHYBF) (CIK 0001672886)
Date: July 18, 2022 · CIK: 0001672886 · Accession: 0001079973-22-000855
AI Filing Summary & Sentiment
File numbers found in text: 333-235983
Letter
VIA EDGAR Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Zhong Yuan Bio-Technology Holdings Limited (SEC File No. 333-235983)
Dear Sir or Madam:
On behalf of Zhong Yuan Bio-Technology Holdings Limited (the “Registrant”), I hereby request that Post-Effective Amendment No. 8 to the Registrant’s Registration Statement on Form F-1, filed with the Commission on June 27, 2022, become effective at 10:00 am (Eastern Daylight Time) on Wednesday, July 20, 2022, or as soon thereafter as possible.
The Registrant acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filings; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Registrant may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the Untied States.
Please note that this letter will be filed with the Commission via EDGAR. In light of the time difference between Washington D.C. and China, if you have any questions or concerns, please contact Celia Velletri, Esq. at (303) 907-4842.
Sincerely,
/s/ CHANG Ting Ting
Show Raw Text
CORRESP
1
filename1.htm
Correspondence
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED
Suite 901, Tesbury Centre
28 Queen’s Road East
Wanchai, Hong Kong
Telephone: + 852 2919-8916
Email: tinachang@zybioholdings.com
July 18, 2022
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Zhong Yuan Bio-Technology Holdings Limited
(SEC File No. 333-235983)
Dear Sir or Madam:
On behalf of Zhong Yuan Bio-Technology
Holdings Limited (the “Registrant”), I hereby request that Post-Effective Amendment No. 8 to the Registrant’s Registration
Statement on Form F-1, filed with the Commission on June 27, 2022, become effective at 10:00 am (Eastern Daylight Time) on Wednesday,
July 20, 2022, or as soon thereafter as possible.
The Registrant acknowledges that
(i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filings; (ii) the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy
of the disclosure in the filing; and (iii) the Registrant may not assert this action as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the Untied States.
Please note that this letter will
be filed with the Commission via EDGAR. In light of the time difference between Washington D.C. and China, if you have any questions or
concerns, please contact Celia Velletri, Esq. at (303) 907-4842.
Sincerely,
/s/ CHANG Ting Ting
CHANG Ting Ting
President, CEO, and Director
c: Austin Wood
Henry F. Schlueter
Celia Velletri